aluates Reports

$ 0.0

Automative

Global Bacteriophage Therapy Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-28C13407

Global Bacteriophage Therapy Market Research Report 2023

BUY CHAPTERS

Global Bacteriophage Therapy Market Research Report 2025

Code: QYRE-Auto-28C13407

Report

June 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Armata Pharmaceuticals, Inc.

Eliava Biopreparations Ltd.

Pherecydes Pharma

Intralytix

Phagelux Inc.

Nextbiotics

Innophage

Locus Biosciences，Inc

TechnoPhage

Eligo Bioscience SA

Phagomed Biopharma GmbH.

PhagePro, Inc.

Adaptive Phage Therapeutics, Inc.

EnBiotix

iNtoDEWorld

BiomX

Phi Therapeutics

Fixed-phage Ltd.

Micreos BV

ContraFect Corporation

Bacteriophage Therapy Market Size

The global market for Bacteriophage Therapy was valued at US$ 38.6 million in the year 2024 and is projected to reach a revised size of US$ 72.7 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Bacteriophage Therapy Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy.

The Bacteriophage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bacteriophage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bacteriophage Therapy Market Report

Report Metric	Details
Report Name	Bacteriophage Therapy Market
Accounted market size in year	US$ 38.6 million
Forecasted market size in 2031	US$ 72.7 million
CAGR	9.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Topical Parenteral
Segment by Application	Organ Transplantation Bacterial Infections Alcoholic Hepatitis Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bacteriophage Therapy Market growing?

Ans: The Bacteriophage Therapy Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Bacteriophage Therapy Market size in 2031?

Ans: The Bacteriophage Therapy Market size in 2031 will be US$ 72.7 million.

Who are the main players in the Bacteriophage Therapy Market report?

Ans: The main players in the Bacteriophage Therapy Market are Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation

What are the Application segmentation covered in the Bacteriophage Therapy Market report?

Ans: The Applications covered in the Bacteriophage Therapy Market report are Organ Transplantation, Bacterial Infections, Alcoholic Hepatitis, Other

What are the Type segmentation covered in the Bacteriophage Therapy Market report?

Ans: The Types covered in the Bacteriophage Therapy Market report are Oral, Topical, Parenteral

Recommended Reports

Infectious Disease Therapies

Therapy and Treatment Markets

Advanced Biologics & Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Topical

1.2.4 Parenteral

1.3 Market by Application

1.3.1 Global Bacteriophage Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Organ Transplantation

1.3.3 Bacterial Infections

1.3.4 Alcoholic Hepatitis

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bacteriophage Therapy Market Perspective (2020-2031)

2.2 Global Bacteriophage Therapy Growth Trends by Region

2.2.1 Global Bacteriophage Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bacteriophage Therapy Historic Market Size by Region (2020-2025)

2.2.3 Bacteriophage Therapy Forecasted Market Size by Region (2026-2031)

2.3 Bacteriophage Therapy Market Dynamics

2.3.1 Bacteriophage Therapy Industry Trends

2.3.2 Bacteriophage Therapy Market Drivers

2.3.3 Bacteriophage Therapy Market Challenges

2.3.4 Bacteriophage Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bacteriophage Therapy Players by Revenue

3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2020-2025)

3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bacteriophage Therapy Revenue

3.4 Global Bacteriophage Therapy Market Concentration Ratio

3.4.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2024

3.5 Global Key Players of Bacteriophage Therapy Head office and Area Served

3.6 Global Key Players of Bacteriophage Therapy, Product and Application

3.7 Global Key Players of Bacteriophage Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bacteriophage Therapy Breakdown Data by Type

4.1 Global Bacteriophage Therapy Historic Market Size by Type (2020-2025)

4.2 Global Bacteriophage Therapy Forecasted Market Size by Type (2026-2031)

5 Bacteriophage Therapy Breakdown Data by Application

5.1 Global Bacteriophage Therapy Historic Market Size by Application (2020-2025)

5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bacteriophage Therapy Market Size (2020-2031)

6.2 North America Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bacteriophage Therapy Market Size by Country (2020-2025)

6.4 North America Bacteriophage Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bacteriophage Therapy Market Size (2020-2031)

7.2 Europe Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bacteriophage Therapy Market Size by Country (2020-2025)

7.4 Europe Bacteriophage Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bacteriophage Therapy Market Size (2020-2031)

8.2 Asia-Pacific Bacteriophage Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Bacteriophage Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bacteriophage Therapy Market Size (2020-2031)

9.2 Latin America Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bacteriophage Therapy Market Size by Country (2020-2025)

9.4 Latin America Bacteriophage Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bacteriophage Therapy Market Size (2020-2031)

10.2 Middle East & Africa Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Bacteriophage Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Armata Pharmaceuticals, Inc.

11.1.1 Armata Pharmaceuticals, Inc. Company Details

11.1.2 Armata Pharmaceuticals, Inc. Business Overview

11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction

11.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.1.5 Armata Pharmaceuticals, Inc. Recent Development

11.2 Eliava Biopreparations Ltd.

11.2.1 Eliava Biopreparations Ltd. Company Details

11.2.2 Eliava Biopreparations Ltd. Business Overview

11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction

11.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)

11.2.5 Eliava Biopreparations Ltd. Recent Development

11.3 Pherecydes Pharma

11.3.1 Pherecydes Pharma Company Details

11.3.2 Pherecydes Pharma Business Overview

11.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction

11.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2020-2025)

11.3.5 Pherecydes Pharma Recent Development

11.4 Intralytix, Inc.

11.4.1 Intralytix, Inc. Company Details

11.4.2 Intralytix, Inc. Business Overview

11.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction

11.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.4.5 Intralytix, Inc. Recent Development

11.5 Phagelux Inc.

11.5.1 Phagelux Inc. Company Details

11.5.2 Phagelux Inc. Business Overview

11.5.3 Phagelux Inc. Bacteriophage Therapy Introduction

11.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.5.5 Phagelux Inc. Recent Development

11.6 Nextbiotics

11.6.1 Nextbiotics Company Details

11.6.2 Nextbiotics Business Overview

11.6.3 Nextbiotics Bacteriophage Therapy Introduction

11.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2020-2025)

11.6.5 Nextbiotics Recent Development

11.7 InnoPhage, Ltd

11.7.1 InnoPhage, Ltd Company Details

11.7.2 InnoPhage, Ltd Business Overview

11.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction

11.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2020-2025)

11.7.5 InnoPhage, Ltd Recent Development

11.8 Locus Biosciences, Inc.

11.8.1 Locus Biosciences, Inc. Company Details

11.8.2 Locus Biosciences, Inc. Business Overview

11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction

11.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.8.5 Locus Biosciences, Inc. Recent Development

11.9 TechnoPhage

11.9.1 TechnoPhage Company Details

11.9.2 TechnoPhage Business Overview

11.9.3 TechnoPhage Bacteriophage Therapy Introduction

11.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2020-2025)

11.9.5 TechnoPhage Recent Development

11.10 Eligo Bioscience SA

11.10.1 Eligo Bioscience SA Company Details

11.10.2 Eligo Bioscience SA Business Overview

11.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction

11.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2020-2025)

11.10.5 Eligo Bioscience SA Recent Development

11.11 Phagomed Biopharma GmbH.

11.11.1 Phagomed Biopharma GmbH. Company Details

11.11.2 Phagomed Biopharma GmbH. Business Overview

11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction

11.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2020-2025)

11.11.5 Phagomed Biopharma GmbH. Recent Development

11.12 PhagePro, Inc.

11.12.1 PhagePro, Inc. Company Details

11.12.2 PhagePro, Inc. Business Overview

11.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction

11.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.12.5 PhagePro, Inc. Recent Development

11.13 Adaptive Phage Therapeutics, Inc.

11.13.1 Adaptive Phage Therapeutics, Inc. Company Details

11.13.2 Adaptive Phage Therapeutics, Inc. Business Overview

11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction

11.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.13.5 Adaptive Phage Therapeutics, Inc. Recent Development

11.14 EnBiotix, Inc.

11.14.1 EnBiotix, Inc. Company Details

11.14.2 EnBiotix, Inc. Business Overview

11.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction

11.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.14.5 EnBiotix, Inc. Recent Development

11.15 Intodeworld, Inc.

11.15.1 Intodeworld, Inc. Company Details

11.15.2 Intodeworld, Inc. Business Overview

11.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction

11.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)

11.15.5 Intodeworld, Inc. Recent Development

11.16 BiomX Ltd.

11.16.1 BiomX Ltd. Company Details

11.16.2 BiomX Ltd. Business Overview

11.16.3 BiomX Ltd. Bacteriophage Therapy Introduction

11.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)

11.16.5 BiomX Ltd. Recent Development

11.17 Phi Therapeutics

11.17.1 Phi Therapeutics Company Details

11.17.2 Phi Therapeutics Business Overview

11.17.3 Phi Therapeutics Bacteriophage Therapy Introduction

11.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2020-2025)

11.17.5 Phi Therapeutics Recent Development

11.18 Fixed-phage Ltd.

11.18.1 Fixed-phage Ltd. Company Details

11.18.2 Fixed-phage Ltd. Business Overview

11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction

11.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)

11.18.5 Fixed-phage Ltd. Recent Development

11.19 Micreos BV

11.19.1 Micreos BV Company Details

11.19.2 Micreos BV Business Overview

11.19.3 Micreos BV Bacteriophage Therapy Introduction

11.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2020-2025)

11.19.5 Micreos BV Recent Development

11.20 ContraFect Corporation

11.20.1 ContraFect Corporation Company Details

11.20.2 ContraFect Corporation Business Overview

11.20.3 ContraFect Corporation Bacteriophage Therapy Introduction

11.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2020-2025)

11.20.5 ContraFect Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Armata Pharmaceuticals, Inc.

Eliava Biopreparations Ltd.

Pherecydes Pharma

Intralytix

Phagelux Inc.

Nextbiotics

Innophage

Locus Biosciences，Inc

TechnoPhage

Eligo Bioscience SA

Phagomed Biopharma GmbH.

PhagePro, Inc.

Adaptive Phage Therapeutics, Inc.

EnBiotix

iNtoDEWorld

BiomX

Phi Therapeutics

Fixed-phage Ltd.

Micreos BV

ContraFect Corporation

List of Tables

Table 1. Global Bacteriophage Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Topical

Table 4. Key Players of Parenteral

Table 5. Global Bacteriophage Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Bacteriophage Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Bacteriophage Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Bacteriophage Therapy Market Share by Region (2020-2025)

Table 9. Global Bacteriophage Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Bacteriophage Therapy Market Share by Region (2026-2031)

Table 11. Bacteriophage Therapy Market Trends

Table 12. Bacteriophage Therapy Market Drivers

Table 13. Bacteriophage Therapy Market Challenges

Table 14. Bacteriophage Therapy Market Restraints

Table 15. Global Bacteriophage Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Bacteriophage Therapy Market Share by Players (2020-2025)

Table 17. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2024)

Table 18. Ranking of Global Top Bacteriophage Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Bacteriophage Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Bacteriophage Therapy, Headquarters and Area Served

Table 21. Global Key Players of Bacteriophage Therapy, Product and Application

Table 22. Global Key Players of Bacteriophage Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Bacteriophage Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Bacteriophage Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global Bacteriophage Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Bacteriophage Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global Bacteriophage Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Bacteriophage Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global Bacteriophage Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Bacteriophage Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Bacteriophage Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Bacteriophage Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Bacteriophage Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Armata Pharmaceuticals, Inc. Company Details

Table 48. Armata Pharmaceuticals, Inc. Business Overview

Table 49. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product

Table 50. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 51. Armata Pharmaceuticals, Inc. Recent Development

Table 52. Eliava Biopreparations Ltd. Company Details

Table 53. Eliava Biopreparations Ltd. Business Overview

Table 54. Eliava Biopreparations Ltd. Bacteriophage Therapy Product

Table 55. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 56. Eliava Biopreparations Ltd. Recent Development

Table 57. Pherecydes Pharma Company Details

Table 58. Pherecydes Pharma Business Overview

Table 59. Pherecydes Pharma Bacteriophage Therapy Product

Table 60. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 61. Pherecydes Pharma Recent Development

Table 62. Intralytix, Inc. Company Details

Table 63. Intralytix, Inc. Business Overview

Table 64. Intralytix, Inc. Bacteriophage Therapy Product

Table 65. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 66. Intralytix, Inc. Recent Development

Table 67. Phagelux Inc. Company Details

Table 68. Phagelux Inc. Business Overview

Table 69. Phagelux Inc. Bacteriophage Therapy Product

Table 70. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 71. Phagelux Inc. Recent Development

Table 72. Nextbiotics Company Details

Table 73. Nextbiotics Business Overview

Table 74. Nextbiotics Bacteriophage Therapy Product

Table 75. Nextbiotics Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 76. Nextbiotics Recent Development

Table 77. InnoPhage, Ltd Company Details

Table 78. InnoPhage, Ltd Business Overview

Table 79. InnoPhage, Ltd Bacteriophage Therapy Product

Table 80. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 81. InnoPhage, Ltd Recent Development

Table 82. Locus Biosciences, Inc. Company Details

Table 83. Locus Biosciences, Inc. Business Overview

Table 84. Locus Biosciences, Inc. Bacteriophage Therapy Product

Table 85. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 86. Locus Biosciences, Inc. Recent Development

Table 87. TechnoPhage Company Details

Table 88. TechnoPhage Business Overview

Table 89. TechnoPhage Bacteriophage Therapy Product

Table 90. TechnoPhage Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 91. TechnoPhage Recent Development

Table 92. Eligo Bioscience SA Company Details

Table 93. Eligo Bioscience SA Business Overview

Table 94. Eligo Bioscience SA Bacteriophage Therapy Product

Table 95. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 96. Eligo Bioscience SA Recent Development

Table 97. Phagomed Biopharma GmbH. Company Details

Table 98. Phagomed Biopharma GmbH. Business Overview

Table 99. Phagomed Biopharma GmbH. Bacteriophage Therapy Product

Table 100. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 101. Phagomed Biopharma GmbH. Recent Development

Table 102. PhagePro, Inc. Company Details

Table 103. PhagePro, Inc. Business Overview

Table 104. PhagePro, Inc. Bacteriophage Therapy Product

Table 105. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 106. PhagePro, Inc. Recent Development

Table 107. Adaptive Phage Therapeutics, Inc. Company Details

Table 108. Adaptive Phage Therapeutics, Inc. Business Overview

Table 109. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product

Table 110. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 111. Adaptive Phage Therapeutics, Inc. Recent Development

Table 112. EnBiotix, Inc. Company Details

Table 113. EnBiotix, Inc. Business Overview

Table 114. EnBiotix, Inc. Bacteriophage Therapy Product

Table 115. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 116. EnBiotix, Inc. Recent Development

Table 117. Intodeworld, Inc. Company Details

Table 118. Intodeworld, Inc. Business Overview

Table 119. Intodeworld, Inc. Bacteriophage Therapy Product

Table 120. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 121. Intodeworld, Inc. Recent Development

Table 122. BiomX Ltd. Company Details

Table 123. BiomX Ltd. Business Overview

Table 124. BiomX Ltd. Bacteriophage Therapy Product

Table 125. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 126. BiomX Ltd. Recent Development

Table 127. Phi Therapeutics Company Details

Table 128. Phi Therapeutics Business Overview

Table 129. Phi Therapeutics Bacteriophage Therapy Product

Table 130. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 131. Phi Therapeutics Recent Development

Table 132. Fixed-phage Ltd. Company Details

Table 133. Fixed-phage Ltd. Business Overview

Table 134. Fixed-phage Ltd. Bacteriophage Therapy Product

Table 135. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 136. Fixed-phage Ltd. Recent Development

Table 137. Micreos BV Company Details

Table 138. Micreos BV Business Overview

Table 139. Micreos BV Bacteriophage Therapy Product

Table 140. Micreos BV Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 141. Micreos BV Recent Development

Table 142. ContraFect Corporation Company Details

Table 143. ContraFect Corporation Business Overview

Table 144. ContraFect Corporation Bacteriophage Therapy Product

Table 145. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)

Table 146. ContraFect Corporation Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Bacteriophage Therapy Picture

Figure 2. Global Bacteriophage Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bacteriophage Therapy Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Topical Features

Figure 6. Parenteral Features

Figure 7. Global Bacteriophage Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Bacteriophage Therapy Market Share by Application: 2024 VS 2031

Figure 9. Organ Transplantation Case Studies

Figure 10. Bacterial Infections Case Studies

Figure 11. Alcoholic Hepatitis Case Studies

Figure 12. Other Case Studies

Figure 13. Bacteriophage Therapy Report Years Considered

Figure 14. Global Bacteriophage Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Bacteriophage Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Bacteriophage Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global Bacteriophage Therapy Market Share by Players in 2024

Figure 18. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2024

Figure 20. North America Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Bacteriophage Therapy Market Share by Country (2020-2031)

Figure 22. United States Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Bacteriophage Therapy Market Share by Country (2020-2031)

Figure 26. Germany Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Bacteriophage Therapy Market Share by Region (2020-2031)

Figure 34. China Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Bacteriophage Therapy Market Share by Country (2020-2031)

Figure 42. Mexico Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Bacteriophage Therapy Market Share by Country (2020-2031)

Figure 46. Turkey Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 50. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 51. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 52. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 53. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 54. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 55. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 56. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 57. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 58. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 59. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 60. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 61. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 62. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 63. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 64. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 65. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 66. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 67. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 68. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bacteriophages Phage Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacteriophages Therapy Service Market Insights Forecast to 2030

Global Bacteriophage Market Insights Forecast to 2030

Bacteriophages Phage Feed Additives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Phage Therapy Kits Market Research Report 2024

Global Ds DNA Bacteriophage Market Insights Forecast to 2030

Bactericide Market

Bacteriophage Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Phage DNA Isolation Kit Market Research Report 2024

Pets Antibiotic Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Phage Display based Antibody Discovery Platform Market Research Report 2025

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Antibiotics Antimicrobials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biofilm Treatment Equipment Market Research Report 2024

Global Antimicrobial Formulations Market Research Report 2024

Antiseptics and Disinfectants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibacterial Drug Resistance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Microbial Solutions Market Research Report 2024

Biocides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6W17226

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34V19460

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6C20013

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K19803

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions